Clinical Trials Directory

Trials / Completed

CompletedNCT02581904

A Randomized Clinical Trial Evaluating Negative Pressure Therapy to Decrease Vascular Groin Incision Complications

Evaluation of Closed Incision Negative Pressure Device (Prevena) to Prevent Vascular Wound Complications

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
140 (actual)
Sponsor
Thomas Jefferson University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if the application of a negative pressure dressing intraoperatively (Prevena; KCI, Inc) to vascular groin incisions decreases the wound complication rate in high risk patients.

Detailed description

The study randomizes patients (1:1) considered high risk, according to a specific set of risk factors, for wound complications into standard post-op dressings vs. Prevena vacuum dressing. The wounds will then be assessed for wound complications in the 30 days postoperatively. Wound complications include breakdown, infection and lymph leak. Patients not considered high risk will have standard post-op dressings and followed similarly to controls. The investigators will also assess economic impact of negative pressure dressing on length of stay and overall inpatient costs.

Conditions

Interventions

TypeNameDescription
DEVICEPrevena CareThe Prevena device is a product from KCI and is a sterile sponge that covers the closed incision. The device is placed sterile in the operating room and suction is then applied to the sponge for 5-7 days.
DEVICEDry gauze dressing careInitial dry gauze dressing will be placed sterile in the operating room and will be changed daily

Timeline

Start date
2015-01-01
Primary completion
2016-12-01
Completion
2017-04-01
First posted
2015-10-21
Last updated
2026-02-25
Results posted
2026-02-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02581904. Inclusion in this directory is not an endorsement.